Phoreus Biotechnology Website, Blog & Press Pages

Phoreus Biotechnology Website, Blog & Press Pages - aVenture

Phoreus Biotechnology - Library

phoreusbiotech.comCrawled Oct 16, 2026

6 pages

BAPtofect-25 .5mg kit/product/05mg-kit
The BAPtofect️-25 .5mg Kit Transfection Reagent insects only. This kit overcomes many of the common transfection issues associated with lipid, protein, and polymer-based products
BAPtofect-25 0.5mg kit - BAPC Transfection Reagent/product/05mg-kit-insect
The BAPtofect️-25 0.5mg Kit Transfection Reagent insects only. This kit overcomes many of the common transfection issues associated with lipid, protein, and polymer-based products
BAPtofect-25 10mg kit - BAPC Transfection Reagent/product/10mg-kit-insect
The BAPtofect️-25 10mg Kit Transfection Reagent insects only. This kit overcomes many of the common transfection issues associated with lipid, protein, and polymer-based products
BAPtofect-25 1mg kit - BAPC Transfection Reagent/product/1mg-kit-insect
The BAPtofect️-25 1mg Kit Transfection Reagent insects only. This kit overcomes many of the common transfection issues associated with lipid, protein, and polymer-based products

6 pages

Blog/blog
View news and articles from Phoreus Biotech. Phoreus Biotechnology, Inc. is the provider of a proprietary technology platform with the capacity to revolutionize global One Health.
New Nanocarrier Technology Promises Breakthrough in Delivery of Therapeutic Drugs Through Mucosal Membranes/blog/new-nanocarrier-technology-promises-breakthrough-in-delivery-of-therapeutic-drugs-through-mucosal-membranes
OLATHE, KS, Apr. 13, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, has announced today a new addition to their
Phoreus Biotech launches BAPtofect-25 peptide transfection reagent as a superior alternative to industry-leading, lipid-based reagents/blog/phoreus-biotech-launches-baptofect-25-peptide-transfection-reagent-as-a-superior-alternative-to-industry-leading-lipid-based-reagents
OLATHE, KS, Mar. 1, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, announced today they’ve added a new product to
Phoreus Biotech Names Steve Schram as CEO/blog/phoreus-biotech-names-steve-schram-as-ceo
OLATHE, KS, September 9, 2021 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, today announces that Steve Schram has been

6 pages

Brian Tosh/team/brian-tosh
Brian is a seasoned marketing and business development professional with over 15 years of experience in healthcare revenue and biotech industries. He
David Schaefer/team/david-schaefer
David has over 30 years of experience in biotechnology and healthcare, spanning diagnostics, medical devices, and therapies in infectious diseases,
Dr. John Tomich, PhD/team/john-tomich
Dr. John Tomich is a professor emeritus of Biochemistry and Molecular Biophysics and the former Director of the Biotechnology/Proteomics Core Facility at
Dr. Raj Pannu, PhD/team/raj-pannu
Raj is the Founder and CEO of Emergence Creative and former Director of Global Health at McCann Health. A behavior change expert, he has advised

1 page

About/about
Phoreus Biotech’s management and business development team has a track record in driving growth and innovation. Its scientists have authored research publications and hold patents.

1 page

1 page

Homepage/
Phoreus Biotech specializes in using nanocarriers to optimize drug delivery.

1 page